Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ru-Rong Ji

Showing results (221-230 of 243) with videos related to

Pageof 25
Sort By:
Neuroscience Bulletin|January 16, 2018
Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodiesSangsu Bang, Jiho Yoo, Xingrui Gong, et al.
Nature Communications|December 31, 2024
Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain reliefNicholas J Wright, Yutaka Matsuoka, Hyeri Park, et al.
Neuron|September 2, 2021
IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female miceXin Luo, Ouyang Chen, Zilong Wang, et al.
Nature|January 7, 2026
Mitochondrial transfer from glia to neurons protects against peripheral neuropathyJing Xu, Yize Li, Charles Novak, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Satellite glial GPR37L1 regulates maresin and potassium channel signaling for pain controlSangsu Bang, Changyu Jiang, Jing Xu, et al.
The Journal of Clinical Investigation|March 26, 2024
Satellite glial GPR37L1 and its ligand maresin 1 regulate potassium channel signaling and pain homeostasisSangsu Bang, Changyu Jiang, Jing Xu, et al.
Oncoimmunology|December 3, 2021
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustionWang Gong, Christopher R Donnelly, Blake R Heath, et al.
The Journal of Pain|January 11, 2021
A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide AgonistJuliet Mwirigi, Moeno Kume, Shayne N Hassler, et al.
The Journal of Investigative Dermatology|January 10, 2022
Skin Injury Activates a Rapid TRPV1-Dependent Antiviral Protein ResponseVivian Lei, Chelsea Handfield, Jeffery T Kwock, et al.
Cell Reports|April 9, 2020
Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic ItchSantosh K Mishra, Joshua J Wheeler, Saumitra Pitake, et al.
Pageof 25

Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
Neuroscience Bulletin|January 16, 2018
Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodiesSangsu Bang, Jiho Yoo, Xingrui Gong, et al.
Nature Communications|December 31, 2024
Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain reliefNicholas J Wright, Yutaka Matsuoka, Hyeri Park, et al.
Neuron|September 2, 2021
IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female miceXin Luo, Ouyang Chen, Zilong Wang, et al.
Nature|January 7, 2026
Mitochondrial transfer from glia to neurons protects against peripheral neuropathyJing Xu, Yize Li, Charles Novak, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Satellite glial GPR37L1 regulates maresin and potassium channel signaling for pain controlSangsu Bang, Changyu Jiang, Jing Xu, et al.
The Journal of Clinical Investigation|March 26, 2024
Satellite glial GPR37L1 and its ligand maresin 1 regulate potassium channel signaling and pain homeostasisSangsu Bang, Changyu Jiang, Jing Xu, et al.
Oncoimmunology|December 3, 2021
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustionWang Gong, Christopher R Donnelly, Blake R Heath, et al.
The Journal of Pain|January 11, 2021
A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide AgonistJuliet Mwirigi, Moeno Kume, Shayne N Hassler, et al.
The Journal of Investigative Dermatology|January 10, 2022
Skin Injury Activates a Rapid TRPV1-Dependent Antiviral Protein ResponseVivian Lei, Chelsea Handfield, Jeffery T Kwock, et al.
Cell Reports|April 9, 2020
Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic ItchSantosh K Mishra, Joshua J Wheeler, Saumitra Pitake, et al.
Pageof 25